AWM Investment Company’s Alto Neuroscience ANRO Stock Holding History

AWM Investment Company’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.11M	Sell	80,000 -90,000	-53%	-$2.08M	0.18%	80
2026 Q1	$3.82M	Sell	170,000 -55,000	-24%	-$1.02M	0.42%	54
2025 Q4	$4M	Sell	225,000 -55,483	-20%	-$699K	0.39%	68
2025 Q3	$1.13M	Hold	280,483	–	–	0.11%	91
2025 Q2	$617K	Sell	280,483 -621,501	-69%	-$1.48M	0.07%	92
2025 Q1	$1.95M	Buy	901,984 +214,153	+31%	+$766K	0.27%	71
2024 Q4	$2.91M	Buy	687,831 +128,100	+23%	+$799K	0.35%	58
2024 Q3	$6.4M	Buy	559,731 +230,500	+70%	+$2.82M	0.78%	45
2024 Q2	$3.52M	Buy	329,231 +30,084	+10%	+$392K	0.48%	58
2024 Q1	$4.59M	Buy	+299,147	New	+$4.68M	0.6%	51

Other funds holding ANRO

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SSC

Spruce Street Capital New York $510M AUM

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AWM Investment Company's ANRO Position: Q2 2026 in Review

AWM Investment Company reduced its Alto Neuroscience (ANRO) stake by 53% in Q2 2026, selling an estimated $2.08M and leaving 80,000 shares worth $2.11M. The position accounts for 0.18% of the portfolio, ranked #80.

AWM Investment Company first reported a position in ANRO in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.4M in Q3 2024. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

AWM Investment Company held 80,000 shares of Alto Neuroscience worth $2.11M as of Q2 2026.
AWM Investment Company sold 90,000 Alto Neuroscience shares in Q2 2026, an estimated $2.08M.
Alto Neuroscience made up 0.18% of AWM Investment Company's portfolio in Q2 2026, its #80 holding.
AWM Investment Company first reported a position in Alto Neuroscience in Q1 2024 and has held it in 10 quarters since.
AWM Investment Company's Alto Neuroscience position peaked at $6.4M in Q3 2024.
114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on AWM Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.